1. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. (28th February 2013) Authors: Barbaud, A.; Collet, E.; Milpied, B.; Assier, H.; Staumont, D.; Avenel‐Audran, M.; Grange, A.; Amarger, S.; Girardin, P.; Guinnepain, M.‐T.; Truchetet, F.; Lasek, A.; Waton, J. Journal: British journal of dermatology Issue: Volume 168:Number 3(2013:Mar.) Page Start: 555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis. (15th April 2019) Authors: Phan, C.; Beauchet, A.; Burztejn, A.‐C.; Severino‐Freire, M.; Barbarot, S.; Girard, C.; Lasek, A.; Reguiai, Z.; Hadj‐Rabia, S.; Abasq, C.; Brenaut, E.; Droitcourt, C.; Perrussel, M.; Mallet, S.; Phan, A.; Lacour, J.‐P.; Khemis, A.; Bourrat, E.; Chaby, G.; Deborde, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 10(2019) Page Start: 1984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characteristics of children and adolescents with atopic dermatitis who attended therapeutic patient education. (29th July 2021) Authors: Barbarot, S.; Boralevi, F.; Shourick, J.; Sampogna, F.; Mahé, E.; Merhand, S.; Bursztejn, A.‐C.; Mallet, S.; Ezzedine, K.; Abasq, C.; Taïeb, C.; Lasek, A.; Bodemer, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 11(2021) Page Start: 2263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Children with psoriasis and COVID‐19: factors associated with an unfavourable COVID‐19 course, and the impact of infection on disease progression (Chi‐PsoCov registry). (6th July 2022) Authors: Zitouni, J.; Bursztejn, A.‐C.; Belloni Fortina, A.; Beauchet, A.; Di Lernia, V.; Lesiak, A.; Thomas, J.; Topkarci, Z.; Murashkin, N.; Brzezinski, P.; Torres, T.; Chiriac, A.; Luca, C.; McPherson, T.; Akinde, M.; Maruani, A.; Epishev, R.; Vidaurri de la Cruz, H.; Luna, P.C.; Amy de la Bretêque, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 11(2022) Page Start: 2076 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical and immunological features and outcome of anti‐p200 pemphigoid. (1st October 2016) Authors: Commin, M.‐H.; Schmidt, E.; Duvert‐Lehembre, S.; Lasek, A.; Morice, C.; Estival, J.‐L.; Debarbieux, S.; Rigal, E.; Pauwels, C.; De Quatrebarbes, J.; Roussel, A.; Goujon, E.; Stoebner, P.‐E.; Jouen, F.; Joly, P. Journal: British journal of dermatology Issue: Volume 175:Number 4(2016) Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical and immunological features and outcome of anti‐p200 pemphigoid. (24th August 2016) Authors: Commin, M.‐H.; Schmidt, E.; Duvert‐Lehembre, S.; Lasek, A.; Morice, C.; Estival, J.‐L.; Debarbieux, S.; Rigal, E.; Pauwels, C.; De Quatrebarbes, J.; Roussel, A.; Goujon, E.; Stoebner, P.‐E.; Jouen, F.; Joly, P. Journal: British journal of dermatology Issue: Volume 175:Number 4(2016) Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dupilumab‐associated hypereosinophilia in patients treated for moderate‐to‐severe atopic dermatitis. (5th March 2021) Authors: Marcant, P.; Balayé, P.; Merhi, R.; Jendoubi, F.; Nosbaum, A.; Raison‐Peyron, N.; Du‐Thanh, A.; Lasek, A.; Ferrier le Bouedec, M.‐C.; Tetart, F.; Valois, A.; Barbarot, S.; Soria, A.; Jachiet, M.; Staumont‐Sallé, D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 6(2021) Page Start: e394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Feelings of guilt in parents of children with atopic dermatitis. (8th October 2021) Authors: Bursztejn, A.C.; Shourick, J.; Bodemer, C.; Lasek, A.; Mahé, E.; Merhand, S.; Sampogna, F.; Taïeb, C.; Boralevi, F.; Ezzedine, K.; Barbarot, S.; Mallet, S.; Abasq, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 2(2022) Page Start: e155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP® scale: prevalence, risk factors and the impact of therapeutic patient education. (30th September 2016) Authors: Gonzales, F.; Ramdane, N.; Delebarre‐Sauvage, C.; Modiano, P.; Duhamel, A.; Lasek, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 3(2017) Page Start: e172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Perceived clinical severity of atopic dermatitis in children: comparison between patients' and parents' evaluation. (24th March 2022) Authors: Mahe, E.; Shourick, J.; Mallet, S.; Abasq, C.; Bursztejn, A‐C.; Sampogna, F.; Bodemer, C.; Boralevi, F.; Barbarot, S.; Lasek, A.; Merhand, S.; Taïeb, C.; Ezzedine, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 7(2022) Page Start: e592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗